Labcorp (NYSE: LH) to present at 2026 Jefferies Global Healthcare Conference
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Labcorp Holdings Inc. will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET. The session will be available via live webcast on the Labcorp Investor Relations website, with an archived recording accessible for 90 days.
The company highlights its global scale, with nearly 71,000 employees serving clients in about 100 countries. Labcorp supported more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performed over 750 million tests for patients worldwide.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Conference presentation time: 12:15 pm–12:45 pm ET
Webcast archive duration: 90 days
Employees: Nearly 71,000 employees
+3 more
6 metrics
Conference presentation time
12:15 pm–12:45 pm ET
Jefferies Global Healthcare Conference on June 3, 2026
Webcast archive duration
90 days
Archived recording access period after conference session
Employees
Nearly 71,000 employees
Global workforce scale
Countries served
Approximately 100 countries
Global client reach
Support for new drugs
More than 85% of FDA approvals in 2025
Share of new drugs and therapeutic products supported
Tests performed
More than 750 million tests
Annual patient testing volume worldwide
Key Terms
webcast, Jefferies Global Healthcare Conference, Inline XBRL, diagnostics, +1 more
5 terms
webcast financial
"The presentation can be accessed via a live webcast on the Labcorp Investor Relations website at ir.labcorp.com."
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
Jefferies Global Healthcare Conference financial
"the company will present at the 2026 Jefferies Global Healthcare Conference in New York"
Inline XBRL financial
"Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
diagnostics technical
"We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities."
Medical diagnostics are tests, tools, and systems that detect, measure, or monitor health conditions—like lab assays, imaging scans, or portable devices that tell whether someone has a disease or how well a treatment is working. For investors, diagnostics matter because they drive recurring revenue, influence healthcare decisions and treatment markets, and can make therapies more or less valuable; think of them as the sensors that guide where money and care get directed.
drug development technical
"through our unparalleled diagnostics and drug development laboratory capabilities."
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Date of earliest event reported)
(Exact Name of Registrant as Specified in its Charter)
| (State or other jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| , | ||||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(Registrant’s telephone number including area code) 336 -229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01. | Regulation FD Disclosure. | ||||
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on May 27, 2026, that the Company will present at the 2026 Jefferies Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
The presentation can be accessed via a live webcast on the Labcorp Investor Relations website at ir.labcorp.com. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed for 90 days following the event.
| Item 9.01. | Financial Statements and Exhibits. | |||||||
| Exhibit | Exhibit Name | |||||||
| Exhibit 99.1 | Press Release dated May 27, 2026 issued by Labcorp Holdings Inc. | |||||||
| Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LABCORP HOLDINGS INC.
Registrant
| Date: May 27, 2026 | By: | /s/ KATHRYN W. KYLE | ||||||
| Kathryn W. Kyle | ||||||||
| Executive Vice President, Chief Legal Officer and Corporate Secretary | ||||||||
FOR IMMEDIATE RELEASE
| Media | Investors | |||||||
| Racquel White | Dewey Steadman | |||||||
| Media@Labcorp.com | Investor@Labcorp.com | |||||||
Labcorp to Present at the Jefferies Global Healthcare Conference
BURLINGTON, N.C., (May 27, 2026) — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET.
The presentation can be accessed via a live webcast on the Labcorp Investor Relations website at ir.labcorp.com. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed for 90 days following the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.
FAQ
What did Labcorp (LH) announce in its latest 8-K filing?
Labcorp announced it will present at the 2026 Jefferies Global Healthcare Conference. The presentation occurs June 3 in New York, with a live webcast and 90-day archived replay available through the company’s Investor Relations website for broader investor access.
When is Labcorp’s presentation at the 2026 Jefferies Global Healthcare Conference?
Labcorp’s presentation is scheduled for Wednesday, June 3, from 12:15 pm to 12:45 pm ET. The event takes place in New York and will be streamed via live webcast on Labcorp’s Investor Relations website, with an archived replay available afterward.
How can investors access Labcorp’s Jefferies conference presentation?
Investors can access the presentation via a live webcast on Labcorp’s Investor Relations site at ir.labcorp.com. An archived, recorded version will be posted roughly 24 hours after the session ends and will remain available for 90 days following the event.
What scale of operations does Labcorp (LH) highlight in this disclosure?
Labcorp notes nearly 71,000 employees serving clients in about 100 countries. The company supported more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performed over 750 million tests globally, underscoring its extensive diagnostics footprint.
What exhibit is included with Labcorp’s 8-K about the Jefferies conference?
The filing includes Exhibit 99.1, a press release dated May 27, 2026. It also lists Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document, providing structured data related to the cover page information for electronic use.
Who are the media and investor contacts for Labcorp (LH)?
Media inquiries are directed to Racquel White at Media@Labcorp.com, while investor questions go to Dewey Steadman at Investor@Labcorp.com. These contacts are listed to support analysts, investors, and journalists seeking more detail about Labcorp’s activities and disclosures.